30

Zhejiang Jolly Pharmaceutical Co Ltd

300181 · SHE · Healthcare / Drug Manufacturers - General

12.05CNY-0.18 (-1.47%)

Price History

Full chart

Market Stats

Previous Close12.23
Open12.28
Day Range12.05 – 12.31
52-Week Range11.98 – 18.45
Volume6.94M
Market Cap9.27B
P/E (TTM)14.52
Forward P/E16.00
EPS0.91
Dividend Yield5.30%
Beta0.12
50-Day Avg13.88
200-Day Avg15.11

About

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. The company offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cephalosporin sinensis, fermented cordyceps, and Wuling powders. It invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. The company was founded in 1995 and is based in Huzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Tao Wang
  • Employees2.86K
  • HeadquartersNo. 388, Zhiyuan North Road, Huzhou, China, 313200, China
  • Websitehttps://zuoli.com

Leadership

  • Mr. Tao WangGM & Non-Independent Director · b. 1968
  • Ms. Li YeDeputy GM & Finance Director · b. 1975
  • Ms. Yuehong ShenDeputy GM & Non-Independent Director · b. 1975
  • Ms. Ying WuSecretary to the Board · b. 1979
  • Mr. Xiao Guo PengDeputy General Manager · b. 1973
  • Ms. Xin TanDeputy General Manager · b. 1987
  • Mr. Aihua MaDeputy General Manager · b. 1966
  • He LengHead of the Accounting Agency & Accounting Supervisor

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue126.59M164.90M215.35M262.66M279.33M343.76M419.42M514.93M670.86M840.04M679.04M730.26M911.16M1.09B1.46B1.81B1.94B2.58B3.04B
Growth (%)-+30.27%+30.59%+21.97%+6.35%+23.07%+22.01%+22.77%+30.28%+25.22%-19.17%+7.54%+24.77%+19.72%+33.60%+23.86%+7.61%+32.71%+17.96%
Cost of Revenue40.77M37.32M45.24M52.14M43.65M50.65M55.09M90.20M210.99M340.08M241.65M277.77M329.89M362.90M420.35M534.65M616.36M1.02B1.17B
Gross Profit85.82M127.58M170.11M210.51M235.67M293.11M364.33M424.73M459.87M499.96M437.39M452.50M581.27M727.98M1.04B1.27B1.33B1.56B1.87B
Gross Margin67.79%77.37%78.99%80.15%84.37%85.27%86.87%82.48%68.55%59.52%64.41%61.96%63.79%66.73%71.16%70.38%68.27%60.48%61.60%
Operating Expense75.75M120.00M138.01M169.76M192.07M237.22M294.51M325.49M379.98M441.89M385.64M421.17M551.97M618.02M812.10M933.29M877.37M949.79M1.08B
Operating Income10.07M7.58M32.10M40.75M43.60M55.88M69.82M99.23M79.89M58.07M51.76M31.33M29.30M109.96M224.95M337.22M448.71M609.29M796.99M
Operating Margin7.96%4.60%14.90%15.52%15.61%16.26%16.65%19.27%11.91%6.91%7.62%4.29%3.22%10.08%15.43%18.68%23.10%23.64%26.21%
EBITDA29.67M33.04M50.47M62.49M73.70M92.27M89.20M125.35M116.73M101.52M101.69M79.84M95.91M171.31M277.87M378.43M483.23M657.69M850.79M
EBITDA Margin23.44%20.04%23.44%23.79%26.39%26.84%21.27%24.34%17.40%12.09%14.98%10.93%10.53%15.70%19.07%20.96%24.88%25.51%27.98%
Net Income13.89M16.64M31.58M41.48M50.93M62.00M81.00M103.18M84.77M72.02M45.14M20.75M25.59M88.80M179.41M273.01M382.94M507.77M631.93M
Net Income Margin10.98%10.09%14.67%15.79%18.23%18.04%19.31%20.04%12.64%8.57%6.65%2.84%2.81%8.14%12.31%15.12%19.71%19.70%20.78%
R&D---10.58M10.03M12.65M19.29M17.59M22.49M22.48M21.33M26.94M27.16M30.39M45.63M64.43M79.38M71.94M69.42M
R&D as % of Total Revenue---4.03%3.59%3.68%4.60%3.42%3.35%2.68%3.14%3.69%2.98%2.79%3.13%3.57%4.09%2.79%2.28%
Interest Expense5.74M6.84M6.67M6.83M6.32M8.42M8.98M9.43M11.77M21.43M17.72M24.17M23.02M18.00M12.40M8.32M7.62M9.45M14.44M
Interest Expense % of Total Revenue4.53%4.15%3.10%2.60%2.26%2.45%2.14%1.83%1.75%2.55%2.61%3.31%2.53%1.65%0.85%0.46%0.39%0.37%0.47%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets251.25M279.87M297.77M348.64M843.91M864.19M941.90M1.18B1.85B2.04B2.15B2.11B2.05B2.47B2.75B3.64B3.63B3.99B4.71B
Total Liabilities106.79M130.76M132.07M141.47M159.99M158.27M169.38M309.75M414.94M566.00M662.06M726.50M642.86M750.43M765.31M879.19M853.09M1.17B1.47B
Total Equity144.47M149.11M165.70M207.17M683.92M705.92M772.52M803.70M1.29B1.32B1.35B1.29B1.31B1.60B1.84B2.70B2.73B2.77B3.18B
Cash14.32M19.33M29.75M44.75M424.35M368.51M357.83M249.31M450.22M330.22M168.75M220.46M138.41M253.75M232.30M1.08B931.98M804.67M680.88M
Total Debt78.40M89.50M99.50M99.00M101.00M93.30M94.92M147.63M253.93M375.00M393.50M461.32M356.53M347.92M206.67M173.13M209.75M426.24M-
Net Debt64.08M70.17M69.75M54.25M-323.35M-275.21M-262.91M-101.68M-196.29M44.78M224.75M240.86M218.12M94.18M-25.63M-908.94M-709.73M-378.43M-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow16.05M31.16M43.89M64.78M13.65M30.51M29.50M13.70M97.13M58.30M6.51M78.28M128.94M279.69M251.80M318.59M288.46M297.05M411.80M
Investing Cash Flow-6.78M-12.47M-19.59M-33.63M-59.77M-32.05M-21.78M-111.50M-330.82M-226.95M-139.08M-1.93M15.13M-121.25M-36.89M-113.34M-263.58M-110.25M-
Financing Cash Flow-11.61M-16.17M-12.09M-15.45M421.98M-53.40M-15.56M-14.33M438.11M42.55M-23.20M-25.26M-226.53M-53.08M-242.95M643.10M-159.32M-339.39M-
Capital Expenditure9.12M12.50M19.60M38.68M61.32M37.05M23.73M39.30M26.08M143.24M124.40M153.92M40.46M58.35M147.95M178.03M131.71M262.89M287.14M
Free Cash Flow6.93M18.66M24.30M26.10M-47.67M-6.54M5.77M-25.60M71.04M-84.94M-117.89M-75.64M88.48M221.34M103.84M140.56M156.75M34.16M124.66M
Dividends Paid10.16M27.27M21.68M8.32M9.14M46.60M20.01M83.90M94.54M68.30M28.27M32.51M48.69M12.17M60.86M121.72M219.95M320.80M423.89M
FCF to OCF43.17%59.88%55.35%40.28%-349.10%-21.42%19.57%-186.96%73.14%-145.68%-1811.94%-96.62%68.62%79.14%41.24%44.12%54.34%11.50%30.27%
Dividend Paid to FCF146.65%146.18%89.24%31.89%-19.18%-712.93%346.67%-327.69%133.07%-80.42%-23.98%-42.98%55.03%5.50%58.61%86.60%140.33%939.13%340.04%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Oct 13, 2014Feb 15, 2015Apr 16, 2015Aug 10, 2015Oct 20, 2015Mar 2, 2016Apr 19, 2016Aug 4, 2016Oct 28, 2016Mar 1, 2017Apr 19, 2017Jul 25, 2017Oct 25, 2017Mar 15, 2018Apr 26, 2018Jul 31, 2018Oct 24, 2018Apr 12, 2019Aug 22, 2019Oct 28, 2019Apr 27, 2020Jul 31, 2020Oct 30, 2020Mar 9, 2021Apr 27, 2021Jul 27, 2021Oct 26, 2021Apr 19, 2022Aug 29, 2022Oct 24, 2022Apr 25, 2023Aug 8, 2023Oct 22, 2023Apr 18, 2024Jul 29, 2024Oct 27, 2024May 9, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------
EPS Actual0.010.040.030.020.020.040.030.030.030.040.040.040.030.050.050.060.040.050.030.020.040.060.03-0.000.020.060.00-0.010.010.04-0.01-0.010.030.02-0.020.030.050.040.040.070.070.110.110.110.140.140.130.140.220.180.260.280.200.170.290.24
Surprise--------------------------------------------------------
Timing--------------Pre-marketPre-marketPre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours-----

Key Statistics & Ratios

Market Cap9.27B
Enterprise Value9.36B
Trailing P/E14.52
Forward P/E16.00
Price / Sales2.89
Price / Book2.77
EPS0.91
Book Value4.78
Revenue (TTM)3.21B
Gross Profit (TTM)1.96B
EBITDA837.32M
Profit Margin19.76%
Operating Margin24.04%
Return on Equity19.80%
Return on Assets9.53%
Shares Outstanding701.39M
Shares Float535.34M
Beta0.12
Dividend Yield5.30%
Dividend Rate0.70
Payout Ratio77.73%

Dividends

20261×
0.35May 28, 2026
20251×
0.60May 26, 2025
20241×
0.45May 22, 2024
20231×
0.30May 30, 2023
20221×
0.20May 31, 2022
20211×
0.10May 31, 2021
20201×
0.02Jun 4, 2020
20191×
0.08May 16, 2019
20181×
0.02May 30, 2018
20171×
0.02May 11, 2017
20161×
0.07Jun 16, 2016
20151×
0.20May 20, 2015
20141×
0.13Mar 4, 2014
20131×
0.03Jun 13, 2013
20121×
0.04Jul 9, 2012

Stock Splits

  • May 20, 201517:10
  • Mar 4, 201422:10
  • Jul 9, 201218:10